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Objective. Disease-modifying treatments for OA remain elusive, and commonly used medications can have serious side effects.
Althoughmeditation andmusic listening (ML) have been shown to improve outcomes in certain chronic pain populations, research
in OA is sparse. In this pilot RCT, we explore the effects of two mind-body practices, mantra meditation (MM) and ML, on knee
pain, function, and related outcomes in adults with knee OA.Methods. Twenty-two older ambulatory adults diagnosed with knee
OA were randomized to a MM (N=11) or ML program (N=11) and asked to practice 15-20 minutes, twice daily for 8 weeks. Core
outcomes included knee pain (Knee Injury and Osteoarthritis Outcome Score [KOOS] and Numeric Rating Scale), knee function
(KOOS), and perceived OA severity (Patient Global Assessment). Additional outcomes included perceived stress (Perceived Stress
Scale), mood (Profile of Mood States), sleep (Pittsburgh Sleep Quality Index), and health-related quality of life (QOL, SF-36).
Participants were assessed at baseline and following completion of the program. Results. Twenty participants (91%) completed the
study (9MM, 11 ML). Compliance was excellent; participants completed an average of 12.1±0.83 sessions/week. Relative to baseline,
participants in both groups demonstrated improvement post-intervention in all core outcomes, including knee pain, function, and
perceived OA severity, as well as improvement in mood, perceived stress, and QOL (Physical Health) (p’s≤0.05). Relative to ML,
the MM group showed greater improvements in overall mood and sleep (p’s≤0.04), QOL-Mental Health (p<0.07), kinesiophobia
(p=0.09), and two domains of the KOOS (p’s<0.09). Conclusions. Findings of this exploratory RCT suggest that a simple MM and,
possibly, ML program may be effective in reducing knee pain and dysfunction, decreasing stress, and improving mood, sleep, and
QOL in adults with knee OA.
1. Introduction
Osteoarthritis (OA) is the most common form of arthritis
and a leading cause of chronic pain and disability in the
U.S., affecting at least 30.8 million American adults [1]. OA is
also associated with increased risk for medical comorbidity
[2, 3], falls [4], and mortality [2, 5, 6] and with significant
deterioration in mood [7, 8], sleep quality [7, 9], and quality
of life (QOL) [5]. OA of the knee, the joint most commonly
affected in OA patients, accounts for 83% of total OA burden
[10, 11]. Approximately 45% of adults are projected to develop
symptomatic knee OA by age 85, and an estimated two-thirds
of those who are obese will develop symptomatic knee OA in
their lifetime [12].
There is currently no cure for OA, and there are no
effective treatments available for modifying the course of
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the disease [13]. Rather, current recommended treatment
approaches focus on symptom management and functional
restoration [13]. Although pharmaceuticals remain the treat-
ment mainstay for the vast majority of patients with OA
[14, 15], medications used to alleviate OA pain can be
costly and carry substantial side effects that are both more
common and more problematic in older adults [16–19].
For example, while the existing literature and guideline
recommendations do not support the use of opioids for the
management of knee OA, these medications are frequently
used [15, 20]. A recent analysis of U.S. commercial and
Medicare claims data from over 6 million privately insured
patients aged 40-75 years (2009-15) indicated that opioid
use is elevated among those with knee OA (33-35%) and
that likelihood of narcotic use was 6- to 8-fold higher in
this population relative to those without diagnosed knee OA
[20].
Of particular concern is the trend of increasing opioid
prescription for OA during the past decade. For example,
opioid use among U.S. adults 65 and older with knee OA rose
from 31% in 2003 to 40% in 2009 [13], despite overwhelming
evidence that opioid therapy for chronic noncancer pain in
older adults carries significant risks. Notably, these medica-
tions are addictive, carry serious side effects, can increase risk
for falls, disability, and all-cause mortality, and are ineffective
for long-term pain control in most [ca 75%] OA patients
[19, 21–23].
The American College of Rheumatology clinical guide-
lines recommend the use of nonpharmacologic therapies
for first-line management of knee OA [24]. Moreover, the
Osteoarthritis Research Society International (OARSI) prac-
tice guidelines emphasize patient-driven therapies and self-
help strategies in the initial stages of OA management [25].
Identifying safe, sustainable self-management interventions
that are effective in addressing not only pain and dysfunction,
but the associated impairment in mood, sleep, and quality of
life is of clear importance.
Movement-based mind-body therapies such as yoga and
tai chi, as well as conventional physical exercise, have been
shown to decrease pain and improve physical function in
older adults withOA [22].There is also growing evidence that
meditation andmusic-based interventions, including simple,
passive music listening, may reduce pain [26–29], improve
mood [26–30], and enhance QOL [28, 29] in adults with OA
and other musculoskeletal [26–28] and chronic noncancer
pain conditions [27, 28, 30]. In our recent uncontrolled
trial of mantra meditation in older adults with knee OA,
participants showed marked and significant improvements
in pain and physical function, mood, and a proxy measure
for sleep following completion of a simple 8-week mantra
meditation program [31]. However, despite the promise and
apparent therapeutic potential of these simple therapies,
rigorous studies regarding the effects of meditation or music
in adults with OA are lacking. Building on our promising
preliminary findings, this exploratory randomized clinical
trial (RCT) compared the effects of a mantra meditation
versus a music listening program on pain, function, and
related psychosocial factors in older adults with symptomatic
OA of the knee.
2. Subjects and Methods
In this community-based pilot RCT, we investigated the
effects of a simple mantra meditation (MM) program versus
a music listening (ML) program on knee pain, function, and
related indices in 22 ambulatory older adults with physician-
confirmed OA of the knee.
2.1. Study Participants: Participant Recruitment, Character-
istics, Screening, and Enrollment. The study was approved
by the West Virginia University Institutional Review Board.
Independently living, ambulatory adults aged ≥50 years with
OA were recruited using flyers and brochures posted in com-
munity, healthcare, and workplace settings, and advertise-
ments posted on the university intranet and listservs. Study
eligibility criteria included: at least 50 years of age; physician-
confirmed diagnosis of OA of the knee; knee pain for at least
6 months, rated as moderately severe or worse (defined as a
score > 3 on an 11-point numeric pain rating scale) for most
days in the month prior to enrollment; and willingness and
ability to abide by the protocol. Exclusion criteria were as
follows: began or stopped medications, physical therapy, or
supplements for the knee within 2 months preceding study
enrollment; intra-articular corticosteroid or hyaluronic acid
injection into the knee within 3 months preceding the study;
significant injury to the knee within the past 6 months;
arthroscopy of the knee within the past year; use of assistive
devices other than a cane or knee brace; presence of an
uncontrolled comorbid condition affecting the knee (e.g.,
rheumatoid arthritis); disease of the spine or other lower-
extremity joints or poor general health interfering with com-
pliance or assessment; a regular meditation practice within
the past year; and/or history of psychotic or schizophrenic
episodes.
Potential participants provided written informed consent
and underwent a full screening and baseline assessment at
the WVU Health Research Center. We enrolled participants
on a rolling basis in two waves over a total of 6 months in
2015-16. Upon completion of the 8-week program, partic-
ipants returned for follow-up assessments (see below). All
participants were encouraged to continue stable use of any
supplements/medications that were currently being taken
for knee pain and to avoid beginning any new drugs or
treatments for knee pain during the study period.
2.2. Randomization. Following provision of consent and
confirmation of eligibility and collection of baseline data
(see below), participants were randomized to the meditation
or music listening group, based on an allocation sequence
generated by the study statistician and using a block ran-
domization method to ensure equal distribution between
treatment groups. The statistician, who had no contact with
the participants, generated an assignmentmaster list and pro-
vided sequentially numbered opaque envelopes containing
the group assignment.The consenting teammember gave the
next envelope in sequence to the participant. The participant
opened the envelope to discover his/her intervention group
assignment.
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2.3. Interventions
2.3.1. Training. Following randomization, each participant
received 30-45 minutes of in-person training in his/her
respective program and received a brief, illustrated reference
guide, a program CD, and a portable CD player for home
use. Each program CD included 15-minute and 20-minute
tracks.The training was provided by a teammember familiar
with both programs and experienced in teaching a variety
of relaxation techniques; training included presentation of
the instructions for each program (described below), intro-
duction to the operation of the CD player and various
CD tracks, and use of the practice log. The participant
then performed their first practice session and recorded it
on the log sheet while the trainer observed and provided
any guidance required by the participant to perform the
intervention at homewith proficiency. In addition, the trainer
followed up with each participant by phone during the first
week of the study, and periodically thereafter as needed to
address any concerns or questions arising during the course
of the trial.
Both interventions entailed sitting comfortably, eyes
closed, for 15-20minutes twice daily every day for 8weeks (112
sessions total) and documenting each session, including any
comments, daily on the practice log provided. All participants
were encouraged to begin the program with the 15-minute
version and move on to the 20-minute version when they
felt comfortable. All participants were instructed to select
a quiet environment where there would be no disturbances
for approximately 20 minutes (see below). Upon completing
the 15-20-minute session, participants were instructed to take
as much time as necessary to gently return to full alertness
before standing up and resuming normal activities.
2.3.2. Mantra Meditation Program (MM). The meditation
technique was a simple, easy-to-learn mantra meditation
practice. A list of possible mantras (sounds or words) was
provided in the instruction sheet. Each participant was
instructed to select a mantra that appealed to him/her based
on the sound or vibrational quality, and to avoidmantras that
might precipitate trains of thought or emotional responses.
The meditation CD contained both guided and silent ses-
sions, including soft chimes to announce the beginning and
end of a 15-20-minute session. Participants were instructed
to take a few deep breaths, releasing any stress or tension
during exhalation, then to begin silently repeating the chosen
mantra, gently letting go of all other thoughts for 15–20
minutes. Emphasis was placed on the practice being easy and
effortless. After 15–20 minutes had passed, the participants
were to stop repeating their mantras and sit quietly for
approximately 2 minutes before opening their eyes.
2.3.3. Music Listening Program (ML). The ML program CD
contained selections of relaxing instrumental music from
each of six composers, including Mozart, Bach, Vivaldi,
Beethoven, Pachelbel, and Debussy (a total of 15 tracks).
Participants were allowed to choose which musical selections
to listen to on a daily basis but were asked to try each
composer at least once during the study.
2.4. Measures and Assessment. All participant assessments
were performed by research staff blinded to participant
treatment assignment.
2.4.1. Baseline Data. These data were collected following
provision of written informed consent. Information gathered
included that on demographics; lifestyle factors (alcohol
consumption, smoking status, caffeine consumption, and
engagement in physical activity); body mass index (BMI,
calculated as height(m)/weight(kg)2); and medical history,
including current use of medications and supplements. At
follow-up, participants were also specifically queried regard-
ing any changes during the study period inmedication and/or
supplement use; caffeine or alcohol consumption, smoking
status, or physical activity.
2.4.2. Outcomes. All outcomes were assessed at baseline
and within 2 weeks following completion of the 8-week
intervention. Core outcomes included knee pain, assessed
using the Knee Injury and Osteoarthritis Outcome Score
[KOOS] [32] and the Numeric Rating Scale [NRS] [33],
knee function (KOOS), and perceived OA severity (Patient
Global Assessment) [34] as consistent with the OMERACT
recommended core set outcomes [35]. All scales are reliable,
well-validated instruments widely used for evaluating knee
OA and shown to be sensitive to change with behavioral and
other nonpharmacologic interventions [36–40].
The KOOS is a self-administered, condition-specific
questionnaire developed as an extension of the Western
Ontario and McMaster Universities Osteoarthritis Index
(WOMAC). In addition to the 17-item subscale to assess knee
function in activities of daily living (ADL) (equivalent to the
WOMAC knee function subscale), the KOOS includes an
expanded 9-item pain subscale and 7-item ”other symptoms”
subscale that incorporate, respectively, the WOMAC knee
pain (5 items) and knee stiffness (2 items) subscales; the
KOOS also includes two additional subscales to evaluate
function in recreational/sport activities and knee-related
quality of life (QOL). Higher scores indicate worse outcomes.
Extensive psychometric testing has shown the KOOS to
be a valid, reliable, and responsive instrument in a range
of populations and across multiple languages [37, 41]. As
aggregate scores are not recommended in scoring the KOOS
[42], the total score (KOOS-WOMAC total) was calculated
as the sum of the WOMAC pain, stiffness, and function
subscale scores as per WOMAC scoring guidelines [43]. An
11-point NRS (ranging from 0 (“no pain”) to 10 (“worst
pain possible”)) was used to rate current, average, least, and
worst pain for the previous week. NRS scales have shown
excellent reliability and validity for a range of populations,
are easier to use, and have shown higher compliance and
greater responsiveness to change with treatment than the
visual analog scale (VAS), especially in older adults [44–48].
Additional outcomes included OA-related quality of life,
symptoms, and function in leisure activities/sports, assessed
using the KOOS subscales for these domains. In addition,
we evaluated perceived stress (10-item Perceived Stress Scale
(PSS) [49]), mood (65-item Profile of Mood States [50]),
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well-being (Psychological Well-Being Scale (PWBS) [51]),
sleep quality (Pittsburgh Sleep Quality Index (PSQI) [52]),
and health-related quality of life (36-item MOS Short Form-
36 (SF-36) [51]). These self-report measures are established,
well-validated instruments that have been used in a broad
range of populations, including those with OA [53–56]. We
also measured pain-related catastrophizing using the 13-item
Pain Catastrophizing Scale (PCS) [57] and fear of movement
using the 6-itemTampa Scale for Kinesiophobia (TSK-6) [58]
to assess change over time in these potential mediators.
2.4.3. Treatment Expectancy, Adherence, and Participant Sat-
isfaction. To assess expectation of benefit, participants com-
pleted an abridged Credibility/Expectancy Questionnaire
(CEQ) following their first intervention practice session;
derived from the original 6-item questionnaire [59], the CEQ
included 2 items scored on a 0-10 scale: ”How confident
are you this program will be beneficial?” and ”What is the
degree of improvement that you expect from this relaxation
program?”. Participants were provided with home practice
logs to complete daily, recording the time and any comments
regarding the daily session; practice logs were collected at the
follow-up assessment. Finally, upon completion of the 8-week
intervention or leaving the study, participants completed an
exit questionnaire adapted from that used in our previous
trials [31, 60–62] and including both structured and open-
ended questions regarding the participants’ experience with
the study, perceived benefits and problems with the interven-
tions, barriers to adherence, and other concerns.
2.5. Data Analysis. All data analyses were performed using
IBM SPSS for Windows, Version 23. Differences in base-
line characteristics by intervention group assignment were
assessed using chi square (for categorical variables), Stu-
dent's independent samples t-tests (for continuous variables
with a normal distribution), or Mann–Whitney U tests (for
ordinal or continuous variables with evidence of skewing).
Potential differences between treatment groups in treat-
ment expectancies, retention, and adherence were analyzed
using chi square (attrition) and one-way ANOVA (adher-
ence, treatment expectancies). In preliminary assessments,
within-group changes over time at 8 weeks were assessed
using ANCOVA with baseline scores as covariates; between-
group differences in treatment outcomes were assessed using
Repeated Measures ANOVA, with factors that differed at
baseline (p<0.1) included as covariates. Variables with a
nonnormal distribution were log-transformed for analysis,
using the addition of a constant in the case of zero or
negative values. We used multiple imputation to replace any
missing data in our intention-to-treat (ITT) analyses [63, 64].
Effect sizes were calculated using Cohen’s d. As this was an
exploratory study designed to assess feasibility and to evaluate
preliminary efficacy for a range of interrelated outcomes of
direct clinical relevance to OA management, the alpha was
set at 0.05 (two-sided) and we did not adjust for multiple
comparisons. While a cut-point of 0.05 can be considered
conservative given the small sample size and objectives of this
exploratory study [65–67], we provide exact p values, along
with effect sizes, point estimates, and measures of variability
to allow readers to draw their own conclusions regarding the
findings.
To assess the potential relationship of treatment
expectancy scores and practice adherence to change over
time in knee pain, function, and related outcomes, as well
as to changes in mood, sleep, well-being, stress, QOL, fear
of movement, and pain catastrophizing, bivariate and age-
and sex-adjusted correlations were performed using Pearson
product-moment correlation. To evaluate the potential
influence of treatment expectancy on change over time
in core outcomes, we also conducted additional analyses
adjusting for this factor.
3. Results
Twenty-two eligible adults with symptomatic OA of the knee
were enrolled in the study. As illustrated in Table 1, study
participants were predominantly non-Hispanic white (82%)
and female (68%), with an average age of 58.5±1.4 (range 50-
74) years. Engagement in physical activity was low overall,
with over 40% reporting none at all, and 68% indicating
less than the recommended 150 minutes/week. BMI averaged
34±1.5, and prevalence of comorbidity was high in this
sample; 82% of participants reported at least one, and 45%
indicated at least 2 chronic comorbid conditions (Table 1).
Common comorbid conditions included obesity (68%) and
hypertension (68%). Prescription medication use was also
high, with 86% reporting using 1-2 and almost 60% at least 3
medications. Most (68%) were on analgesics, with 32% using
opioids or muscle relaxants and 59% reporting regular use of
NSAIDs. Clinically significant sleep impairment, defined as
PSQI>5 [52, 68], was present in over 95% of participants at
baseline, and psychosocial measures indicated high baseline
levels of distress in this population (Table 2). Treatment
expectancy scores indicated positive expectations overall,
with both items averaging over 7 on a scale of 1-10 (means
± SE=7.8±0.3, 7.2±0.4).
Participants in the MM group averaged higher baseline
BMI and were more likely to indicate absence of physical
activity and to report higher analgesic (and specifically
NSAID) use than those of the ML group. The two groups
did not differ significantly in other demographic character-
istics, lifestyle factors, medical history, or medication use
(Table 1). Likewise, there were no significant between-group
differences in baseline scores on core or secondary outcome
measures (Table 2) or in measures of kinesiophobia or pain
catastrophizing (p’s >0.1).
Each participant received the intervention as allocated.
Participant retention was high, with 20/22 (91%) participants
(9/11 MM, 11 ML) completing the 8-week intervention.
Drop-out occurred early in the study, with one participant
withdrawing in week one due to a job change and the second
in week two due to an injury unrelated to the intervention.
Adherence was also high, with participants completing an
average of 94% of the 112 possible sessions (91% MM,
96% ML) and an average of 13.1±0.4 sessions/week (12.8±8
MM, 13.5±0.3 ML).There were no significant between-group
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Table 1: Participant baseline characteristics: pilot RCT of an 8-week mantra meditation (MM) and an 8-week music listening (ML) program
in 22 adults with symptomatic osteoarthritis of the knee.
Overall (N=22) MM (N=11) ML (N=11) P
N % N % N %
Demographic characteristics
Age (range 50-74 years) 1.00
50-59 years 14 63.64% 7 63.64% 7 63.64%
60+ years 8 36.36% 4 36.36% 4 36.36%
Mean±SE 58.46±1.37 58.09±1.60 58.82±2.23 0.73
Gender 0.22
Female 15 68.18% 9 81.82% 6 54.55%
Male 7 31.82% 2 18.18% 5 45.45%
Race/Ethnicity
Non-Hispanic White 18 81.82% 9 81.82% 9 81.82% 1.00
Minority 4 18.18% 2 18.18% 2 18.18%
Education 0.37
12 years or less 2 9.09% 1 9.09% 1 9.09%
Some post-high school education 8 36.36% 6 54.55% 2 18.18%
4 years of college or more 12 54.55% 4 36.36% 8 72.73%
Mean±SE in years 15.46±0.42 15.09±0.64 15.82±0.57 0.41
Employment status 0.72
Employed full time 15 68.18% 8 72.73% 7 63.64%
Other 7 31.82% 3 27.27% 4 36.36%
Marital status 0.54
Married/co-habiting 16 72.73% 7 63.64% 9 81.82%
Divorced/Widowed 6 27.27% 4 36.36% 2 18.18%
Lifestyle and health-related factors
Smoking status 1.00
Never smoked 18 81.82% 9 81.82% 9 81.82%
Ever smoker 4 18.18% 2 18.18% 2 18.18%
Caffeinated beverage consumption 0.39
0-16 oz/d 14 63.64% 8 72.73% 6 54.55%
17+ oz/day 8 36.36% 3 27.27% 5 45.45%
Mean oz consumed/day±SE 14.52±2.46 13.82±3.67 15.22±3.46 0.78
Physical activity 0.04
None 9 40.91% 7 63.64% 2 18.18%
10-149 min/week 6 27.27% 3 27.27% 3 27.27%
150+ min/week 7 31.82% 1 9.09% 6 54.55%
Mean minutes/week±SE 148.64.64±50.74 129.09±96.57 168.18±37.53 0.71
Mean times/week±SE 3.07±0.63 2.00±0.88 4.14±0.81 0.09
Body mass index (BMI): Mean±SE 34.02±1.45 37.03±1.91 31.01±1.82 0.03
Obese 15 68.18% 9 81.82% 6 54.55% 0.17
History of diagnosed:
Diabetes 1 4.55% 0 0.00% 1 9.09% 0.72
Hypertension 15 68.18% 8 72.73% 7 63.64% 0.65
High cholesterol 7 31.82% 4 36.36% 3 27.27% 0.65
Depression 6 27.27% 4 36.36% 2 18.18% 0.34
Anxiety disorder 4 18.18% 2 18.18% 2 18.18% 1.00
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Table 1: Continued.
Overall (N=22) MM (N=11) ML (N=11) P
N % N % N %
Number of comorbid conditions 0.66
None 4 18.18% 2 18.18% 2 18.18%
One 8 36.36% 3 27.27% 5 45.45%
Two or more 10 45.45% 6 54.55% 4 36.36%
Medications
Analgesic Medications 15 68.18% 10 90.91% 5 45.45% 0.03
Opioids/Muscle relaxants 7 31.82% 3 27.27% 4 36.36% 0.45
NSAIDS 13 59.09% 9 81.82% 4 36.36% 0.03
Anti-depressant/anti-anxiety
medications 8 36.36% 5 45.45% 3 27.27% 0.38
Anti-hypertensive medications 15 68.18% 8 72.73% 7 63.64% 0.65
Statins, other lipid-lowering
medications 7 31.82% 3 27.27% 4 36.36% 0.65
Other medications∗ 12 54.55% 6 54.55% 6 54.55% 0.72
Total medications 0.23
None 3 13.64% 0 0.00% 3 27.27%
1-2 6 27.27% 3 27.27% 3 27.27%
Three or more 13 59.09% 8 72.73% 5 45.45%
∗Includingmedications for gastrointestinal reflux, diabetes, thyroid disorders, and osteoporosis.
differences in adherence (p’s≥0.4). Similarly, there were no
significant differences between the two groups in treatment
expectancy (p’s≥0.7). Treatment expectancy scores were neg-
atively related to improvements over time in one measure
of pain (NRS, average pain), overall mood, depression, and
quality of life (r’s ranging from -0.4 to -0.6, p’s<0.05). No
adverse events were observed or reported.
Responses on the exit questionnaires (N=20) also indi-
cated overall high satisfaction with the study and study
interventions. Eighty percent of participants (78% MM, 82%
ML) indicated that they were likely or very likely to continue
practicing. In response to the question “What did you like
most about the study?”, 65% (78% MM, 55% ML) reported
they enjoyed taking time for themselves; 80% (78% MM,
82% ML) indicated that they found the practice to be
soothing, calming, and/or relaxing; a number also noted
their practice to help with pain (40%) and/or sleep (30%).
Several (4 MM, 1 ML) noted experiencing increased focus,
clarity, and/or awareness. In response to questions regarding
challenges/barriers experienced in the study or program, 7
participants (3 MM, 4 ML) indicated no difficulties/barriers;
others noted difficulty finding time to complete the practice
(3 MM, 4 ML), with some (N=4) noting they felt the practice
was too or a bit too long.
3.1. Change over Time in Knee Pain-Related Outcomes, Psy-
chological Status, Sleep Quality, and Quality of Life. As illus-
trated in Table 3, participants in both groups demonstrated
improvement at 8 weeks in primary outcomes, including
knee pain (KOOS, p’s≤0.03; NRS, p’s<0.05) and perceived OA
severity (PGA, p’s≤0.04), as well as in current, average, and
least knee pain (NRS, p’s≤0.03). In addition, the MM group
demonstrated significant gains in knee function (p<0.02),
sport and recreation-related function (p=0.04), and knee-
related quality of life (p<0.03). Although both effect sizes
and absolute improvements in most measures were substan-
tially larger in the MM than in the ML group, between-
group differences were marginally significant for only the
overall total (WOMAC) score and two KOOS subscales,
sport/recreational function and knee-related QOL (Table 3).
Using the OARSI/OMERACT criteria for treatment response
in clinical trials of OA [69], the percentage of responders
was also greater in the MM than in the ML group (67%
versus 54%, respectively), but differenceswere not statistically
significant.
Participants in both the MM and ML group also demon-
strated improvements in perceived stress (p’s≤0.04) andQOL
(Physical Health Component, p<0.01), as well as reductions
in fear of movement (TKS, p≤0.05) and pain catastrophizing
(PCS, MM, p<0.09, ML p<0.01) (Table 3). In addition,
the MM group showed significant improvements in sleep
quality (p<0.02 for overall, p’s≤0.03 for sleep disturbance
and daytime dysfunction), overall QOL-MH (p=0.01), overall
mood (p<0.01), and multiple individual domains of both
mood (confusion, depression, anger/hostility, and fatigue
(p’s≤0.04)) and QOL (energy/vitality, emotional well-being,
and pain (p’s≤0.04)).
Relative to ML, the MM group showed significantly
greater improvements in overall sleep quality and mood
(p’s≤0.04) and in two individual mood domains, including
tension/anxiety and anger/hostility (p’s=0.01). Participants
Evidence-Based Complementary and Alternative Medicine 7
Table 2:Mean baseline scores on osteoarthritis (OA) knee pain, function, and related outcomes and on sleep, stress,mood, well-being, quality






Mean (SE) Mean (SE)
Knee Pain-Related (Core) Outcomes
Knee Injury and OA Outcome Score (KOOS)
Total-WOMAC∗(range 0-240) 106.64 (6.54) 119.73 (12.70) 0.37
Pain (range 0-90) 41.91 (2.41) 49.82 (4.38) 0.16
Pain-WOMAC (range 0-50) 20.90 (0.96) 25.82 (2.92) 0.14
Symptoms (range 0-70) 32.64 (2.90) 33.73 (3.09) 0.89
Stiffness-WOMAC (range 0-20) 10.82 (0.93) 12.45 (1.03) 0.25
Function (range 0-170) 74.90 (5.57) 81.46 (9.43) 0.56
Sports/Recreation (range 0-50) 35.73 (3.58) 34.91 (4.08) 0.88
Quality of Life (range 0-40) 29.82 (1.83) 29.18 (2.45) 0.84
Numeric Rating Scale (range 0-10)
Pain now 3.90 (0.50) 4.27 (0.69) 0.67
Average pain (last week) 4.91 (0.31) 5.91 (0.56) 0.15
Worst pain (last week) 7.20 (0.57) 7.82 (0.0.62) 0.47
Least pain (last week) 2.80 (0.36) 2.73 (0.0.78) 0.93
Patient Global Assessment (range 0-10) 6.00 (0.36) 6.36 (0.53) 0.57
Secondary Outcomes
Stress, Sleep Quality, Mood, andWell-being
Perceived Stress Scale 17.30 (3.24) 15.33 (1.32) 0.25
Pittsburgh Sleep Quality Index 9.78 (3.24) 8.09 (2.21) 0.23
Profile of Mood States (total score) 30.90 (11.19) 29.37 (11.19) 0.93
Psychological Well-being Scale 84.73 (3.70) 82.64 (5.05) 0.74
Health related Quality of Life (SF-36)
Mental Health Composite Score 60.20 (6.92) 70.00 (6.43) 0.31
Physical Health Composite Score 45.74 (4.85) 47.90 (5.62) 0.77
Potential mediators
Tampa Scale for Kinesiophobia 17.30 (1.02) 16.82 (0.76) 0.71
Pain Catastrophizing Scale 15.10 (3.92) 22.27 (3.98) 0.21
Treatment Expectancy(CEQ)
How confident that tx will be beneficial (1-10) 7.73 (0.41) 7.82 (1.25) 0.78
Degree improvement expected (1-10) 7.00 (0.49) 7.27 (0.45) 0.96
∗Calculated as the sum of the WOMAC Pain, Stiffness, and Function subscale scores.
CEQ= Credibility Expectancy Questionnaire (higher numbers indicate higher expectancy).
assigned to MM also tended to show greater gains in
QOL-Mental Health (MH) (p<0.07), as well as in certain
individual domains ofmood (depression (p=0.06), confusion
(p=0.09)) and QOL-PH (pain, general health (p’s<0.09)).
ITT analyses using multiple imputation yielded similar
results, as did analyses adjusting for baseline physical activity.
Additional adjustment for treatment expectancy modestly
strengthened the between-group differences inmood (overall
and depression (p’s≤0.03), sleep (p=0.02), and QOL-MH
(p=0.04)) but did not otherwise appreciably alter findings in
age-adjusted analyses. Three participants reported a change
in medication, including two MM (lowered dose of ACE
inhibitor (1), given a 3-day prescription for muscle relaxant
for pain unrelated to OA (1)) and 1 ML participant (pre-
scribed narcotic analgesic). Neither adjusting for change
in medication nor eliminating these individuals from the
analyses substantively altered the within-group or between-
group findings.
3.2. Relation of Changes over Time in Knee Pain and Related
Outcomes toThose in Psychological Status, SleepQuality, Qual-
ity of Life, and Other Factors. As illustrated in part in Table 4,
improvements inmood, both overall and in specific domains,
were significantly correlated with declines in current pain
(NRS, r’s=0.5 overall; 0.4-0.5, tension, vigor; p’s<0.05) and
improvements in patients’ assessment of their condition
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Table 3: Change over time in knee pain, function, perceived stress, sleep, mood, and related outcomes in older adults with knee osteoarthritis
assigned to a mantra meditation or music listening program.
Mantra Meditation Music Listening
Change at 2 months Change at 2 months
(Mean ± SE) P∗ ES (Mean ± SE) P∗ ES P
Knee Pain-Related (Core) Outcomes
KOOS
Total (WOMAC)∗∗ -38.00 (12.27) 0.015 2.2 -19.00 (8.82) 0.06 0.5 0.07
Pain -13.33 (4.45) 0.02 0.7 -9.36 (3.77) 0.03 0.7 0.16
WOMAC pain -8.00 (2.74) 0.02 2.3 -4.82 (2.47) 0.08 0.5 0.26
Symptoms -5.22 (2.67) 0.08 0.7 -2.55 (1.98) 0.23 0.3 0.42
Stiffness (WOMAC) -2.00 (1.35) 0.18 0.4 -1.91 (0.78) 0.03 0.5 0.95
Function (ADL) -28.00 (8.91) 0.02 0.8 -12.27 (6.67) 0.10 0.4 0.45
Sports/Recreation -17.00 (7.06) 0.04 0.9 -2.91 (4.96) 0.57 0.2 0.09
Knee-related Quality of Life -8.67 (3.19) 0.03 0.8 -1.91 (1.52) 0.24 0.2 0.06
Numeric Rating Scale
Knee pain now -1.63 (0.50) 0.01 1.0 -1.73 (0.66) 0.03 0.8 0.58
Average knee pain -2.13 (0.79) 0.03 1.6 -1.45 (0.47) 0.01 0.8 0.90
Worst knee pain -1.38 (0.53) 0.04 0.7 -1.18 (0.50) 0.12 0.6 0.94
Least knee pain -1.63 (0.42) 0.01 1.3 -1.64 (0.66) 0.03 0.6 0.65
Patient Global Assessment -2.00 (0.87) 0.025 1.0 -1.18 (0.50) 0.04 0.7 0.19
Secondary Outcomes
Stress, mood, well-being and sleep quality
Perceived Stress Scale -4.78 (2.00) 0.04 0.7 -3.45 (1.08) 0.01 0.4 0.56
Profile of Mood States (total score) -34.11 (9.64) 0.008 1.5 -10.91 (5.19) 0.06 0.2 0.04
Psychological Well-being Scale 4.00 (3.09) 0.23 0.4 2.45 (2.44) 0.34 0.2 0.74
Pittsburgh Sleep Quality Index (total score) -2.38 (0.80) 0.02 0.7 -0.36 (0.49) 0.48 0.1 0.04
Health related Quality of Life (SF-36)
Mental Health Component 17.96 (5.61) 0.01 0.9 5.30 (3.63) 0.18 0.2 0.07
Physical Health Component 20.69 (5.11) 0.004 1.0 11.59 (3.76) 0.01 0.5 0.16
Potential Mediators
Tampa Scale for Kinesiophobia-6 (total) -4.22 (1.53) 0.03 1.1 -1.45 (0.65) 0.05 0.7 0.09
Pain Catastrophizing Scale Total -4.78 (2.48) 0.09 0.5 -7.64 (2.24) 0.007 0.7 0.25
∗Repeatedmeasures ANOVA (RM)  Between group difference at 2 months, adjusted for age.
∗∗Calculated as the sum of the WOMAC Pain, Stiffness, and Function subscale scores.
Abbreviations: ES= effect size; KOOS=Knee Injury and Osteoarthritis Outcome Score; SE=standard error.
overall (PGA) (fatigue, r=0.65, p<0.005). Reductions in NRS
measures of knee pain and OA-related symptoms (KOOS)
were significantly correlated with several individual domains
of sleep quality (r’s=0.5-0.6, sleep latency, quality, duration,
and disturbance) and with increases in mean hours of sleep
(r’s=0.5). Positive changes in mental and physical health-
related quality of life, both overall and specific domains, were
significantly correlated with improvements in several knee
pain related outcomes, including overall knee-related symp-
toms and function (KOOS-WOMAC total score) and KOOS
knee function (r’s 0.5-0.6 overall; 0.4-0.5, individual domains
(emotional well-being, energy/vitality, social function, pain,
and physical function)), current and average knee pain (NRS,
r’s=0.4-0.5 overall; 0.5-0.7, emotional well-being, physical
function), PGA (r’s=0.4-5 overall and individual domains
(emotional well-being, energy/vitality, social function physi-
cal function)), and knee-relatedQOL (r’s=0.4-0.5 overall; 0.4-
0.5, emotional well-being, physical function). In addition,
decline in fear of movement was significantly correlated with
improvements in average pain scores (r=0.6), OA severity
(r=0.6), and all KOOSmeasures except knee pain (r’s 0.4-0.6),
supporting a possible mediating influence of kinesiophobia.
Declines in pain catastrophizing (PCS) were correlated only
with improvements in the KOOS symptoms subscale (r=0.5)
(Table 4).
Baseline scores on perceived stress, mood, well-being,
sleep quality, and overall QOL were significantly intercorre-
lated (r’s ranging from 0.4 to 0.9). As illustrated in Table 5,
improvements in mood, perceived stress, sleep quality, and
both the mental and physical health components of QOL
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Table 5: Relation between changes over time in mood, sleep, perceived stress, and quality of life in adults with knee osteoarthritis.
Change from baseline
Change over time at 2 months
Mood Perceived Stress Sleep Quality QOL, Mental Health QOL, Physical Health
Mood (Profile of Mood States) 0.66 0.54∗∗ -0.75 -0.57∗∗∗
Perceived stress (Perceived Stress Scale) 0.66 0.48∗ -0.44∗ -0.56∗∗∗




Mental Health Component -0.75 -0.44∗
Physical Health Component -0.57∗∗∗ -0.56∗∗∗
∗p<0.05; ∗∗P<0.025; ∗∗∗p<0.01; p<0.005; p<0.001.
Abbreviations:QOL=quality of life.
were likewise strongly interrelated at 2 months (r’s from 0.4
to 0.8), with the strongest correlations observed between
changes in mood and those in stress and the mental health
composite score (r’s from 0.7 to 0.8). Improvements in
sleep quality were likewise correlated strongly with those in
mood and perceived stress (r’s=0.5). No statistically signif-
icant relationships were observed between changes in pain
catastrophizing or kinesiophobia scores and any measure of
psychosocial status.
4. Discussion
In this pilot RCT, participants assigned to both MM and
ML demonstrated significant reductions in knee pain and
overall OA severity. The MM group also showed significant
improvements in multiple domains of knee function and
greater gains than the ML group in two of these domains
(knee-related QOL and sports/recreation-related function),
as well as in overall (KOOS-WOMAC) score. Although cri-
teria for minimal clinically important improvements (MCII)
in the KOOS total score and in the KOOS pain and QOL
subscales have not yet been established, improvements in
the MM group in both the overall KOOS-WOMAC score
and in all subscales far exceeded cutoffs proposed using a
variety of differentmethods and anchors, including effect size
(minimum 0.5) [70] and absolute change [71]. Similarly, the
mean KOOS pain and function scores in the ML group also
met or exceeded proposed cutoffs for MCIIs for knee pain
and function, although effect sizes were substantially smaller
overall than in the MM group. Using the more stringent
criteria for the WOMAC pain and function subscales, the
MM group achieved clinically significant improvement and
an acceptable symptom state for pain and function, whereas
the ML group did not [72, 73]. Likewise, only the MM
group showed clinically important improvement in pain as
measured by PGA, although both groups met criteria for
clinically important reductions in the NRS [45, 74].
Although knee OA is a complex condition that remains
incompletely understood [75], multiple interrelated factors
likely contribute to the etiology and progression of OA.These
include physical, neurobiological, and physiologic factors
(e.g., altered neurologic structure and function, inflamma-
tion, joint degeneration, obesity, deterioration in muscular
strength and cardiovascular fitness, and pain sensitization) as
well as psychosocial and behavioral factors (e.g., sleep impair-
ment, mood disturbance, low social support, pain-related
fear, avoidant coping strategies, and sedentary behavior) [31,
76–78]. OA pain and dysfunction have been bidirectionally
linked to distressful states andmaladaptive behaviors, includ-
ing psychologic stress [8, 79–81], depression and anxiety [79,
82–84], sleep impairment [7, 9, 85–87], fatigue [8, 84, 88],
pain-related fear, [79, 89, 90], and catastrophizing [79, 91–
94]. Consistent with both the biopsychosocial [95] and fear-
avoidance models of knee OA [92, 96, 97], these reciprocal
relationships contribute to a vicious cycle of increasing
distress, sleep disturbance, fatigue, pain and pain sensitivity,
sedentary behavior, and physical dysfunction, further ampli-
fying risk for disability, morbidity, andmortality [8, 86, 91, 92,
98, 99]. Thus, therapies which address the key psychosocial
dimensions of knee OA, in turn, strong determinants of
OA pain and dysfunction, may be of particular benefit in
the management of this serious and common chronic pain
disorder.
To our knowledge, this is the first RCT to assess the
effects of a simple meditation practice on pain, function, or
related outcomes in patients with OA of the knee. Previous
controlled studies in mixed and other pain populations
suggest other meditation based interventions may improve
pain and certain psychosocial outcomes in adults with mus-
culoskeletal disorders, although observed effects have been
modest overall. Notably, in a recent meta-analysis of 38 RCTs
of mindfulness-based interventions in adults with chronic
pain, including 3 studies with a small percentage (4-7%) of
participants with OA or nonspecific arthritis, authors found
low quality evidence for an overall small reduction in pain
and for modest improvements in depression and QOL [28].
Likewise, this study is among the first to assess the effects
of ML on OA pain and the first to evaluate potential benefits
of ML for improving other outcomes of relevance to OA.
Only one controlled trial has assessed the potential benefit of
ML for OA, an RCT of 66 community-dwelling elders with
symptomatic OA [100]. Consistent with our findings, elders
randomized to a 14-day dailyML program showed significant
reductions in pain over time relative to those randomized to
daily quiet sitting [100]. Our findings are also in agreement
with those from a recent meta-analysis of 14 RCTs of music
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listening (N=13) and other music interventions (N=1) for a
range of chronic pain conditions, which indicated significant,
moderate reductions in pain overall [27].
Observed improvements in OA pain and function in this
study were also comparable or superior to those reported
in studies of other nonpharmacologic therapies for knee
OA, including acupuncture [101, 102], massage [103], yoga
[40, 104–108], t’ai chi [109–111], and other forms of exercise
[102, 112]. Notably, effect sizes for knee pain and function in
theMMgroupwere large (range 0.7-1.6), comparable to those
reported for 8 weeks of physical therapy in patients with knee
OA [41].
In addition, the reductions in pain and overall improve-
ments in function observed in this study were also similar to
or greater than those reported in previous trials of medica-
tions commonly prescribed for OA, including nonsteroidal
anti-inflammatory drugs [113], acetaminophen [114], and
opioids [113, 115]. Moreover, drug side effects can significantly
mitigate the benefits of pharmaceuticals forOAmanagement.
For example, in a recent Cochrane review of oral and trans-
dermal opioids for OA, the authors concluded that the small
to moderate effects of these medications were outweighed
by potential side effects and cautioned clinicians to discuss
alternative treatments with patients [115]. Likewise, Machado
et al. concluded that acetaminophen provides minimal short
term benefit for OA, effects that are offset by significantly
increased risk for elevated liver enzymes [114].
In this study, both the MM and ML groups also indi-
cated significant improvements in perceived stress, overall
mood, and QOL-Physical Health component. Relative to
those assigned to ML, the MM group participants showed
significantly greater improvement in mood and greater gains
in QOL-MH. No published RCTs in OA patients have yet
assessed the potential benefits of meditation or ML on
psychosocial outcomes of relevance to OA. However, the
improvements inmood andQOL observed in this study were
similar to or greater than the effects documented in previous
studies of yoga [116], tai chi [117, 118], physical therapy [117],
exercise [112], and other nonpharmacologic therapies [119,
120] in adults with OA. Likewise, effect sizes in the MM
group were comparable to or greater than those observed in
controlled trials of mindfulness meditation [28] and music
listening [27, 29] in other chronic pain populations.
In addition, those randomized to MM but not to ML
showed significant improvements in sleep quality in this
exploratory trial (p for between-group difference<0.04).
Although there is evidence that music listening, meditation,
yoga, and other mind-body and physical activity interven-
tions may improve sleep in older adults [121–127], few trials
of patients with OA or other chronic pain conditions have
measured sleep as an outcome, and findings of these studies
have beenmixed [116, 128–131]. For example, evidence to date
has indicatedmodest or no effects of yoga on sleep inOA [116]
and inconsistent findings for the benefits of tai chi in another
chronic pain syndrome, fibromyalgia [129–131].
In the current trial, both the MM and ML groups
showed reductions in kinesiophobia, although the effect size
was greater in the MM group. Pain catastrophizing was
significantly reduced only in the ML group. Pain-associated
catastrophizing and fear of movement are thought to con-
tribute to the development and persistence of chronic pain;
these factors may influence pain severity both directly and
indirectly, and are significant predictors of physical per-
formance and pain-related disability in those with chronic
pain [79, 91, 92, 132, 133]. However, although kinesiophobia
and pain-related catastrophizing have been recommended
for inclusion in clinical trials of lifestyle interventions for
OA [134], published RCTs regarding the effects of medita-
tion, ML, yoga, or other mind-body interventions on these
endpoints remain sparse. Moreover, findings from studies
in other chronic pain populations have been mixed. In
broad agreement with our findings, some studies suggest that
certain yoga [135], mindfulness [136–139], and exercise-based
interventions [140, 141] can be effective in lowering fear of
movement [135, 136, 140, 141] and/or catastrophizing [137–
139] in those with chronic pain, although other studies have
reported modest or no effects [142–144].
Possible Underlying Mechanisms. While the mechanisms
underlying the improvements in knee-related pain and func-
tion observed with MM and, albeit to a lesser extent, ML
remain speculative, these simple mind-body therapies likely
act via several pathways. Both meditation and music have
been shown to decrease stress and stress reactivity, sleep
impairment, anxiety, depression, fatigue, and sympathetic
arousal [28, 121, 122, 145–151], factors linked to increased
pain sensitivity and severity [8, 152–155]. As indicated above,
there is a growing literature supporting the importance of
sleep [9, 85, 86], mood [8, 84, 154], and other psychosocial
factors [8, 79, 98] as both sequelae and determinants of OA
associated pain, dysfunction, and disability. Consistent with
these bidirectional relationships, improvements in knee pain,
function, and other OA-related outcomes were positively
correlated with improvements in mood, sleep, and QOL in
this study.
Likewise, meditation andmusic may improve OA-related
pain and function by reducing pain-associated fear of move-
ment, a factor linked to the development and progression of
chronic pain and associated disability, to the adverse mood
and functional alterations associated with OA [132], and to
the reluctance to engage in physical activity that is common
among those with OA [90, 92, 156]. In this study, declines in
fear of movement were greater in the MM than in the ML
group and were strongly correlated with improvements in
pain and function and, albeit more modestly, with those in
mood, supporting a potential functional relationship. These
findings suggest that reductions in kinesiophobia may in part
mediate the observed beneficial effects of these simple mind-
body practices on OA-related pain, function, symptoms, and
mood changes, consistent with both the biopsychosocial and
fear-avoidance models of chronic pain [92, 95–97, 132].
Finally, meditation and ML may also reduce pain by
promoting beneficial functional and structural changes in
brain structures associated with pain processing, attention,
cognition, emotional regulation, and reward [157–165].These
alterations may, in turn, lead to a reduction in the central
pain sensitization and hyperalgesia associated with OA [166–
168]. For example, emerging evidence suggests that both
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meditation and ML can induce beneficial changes in central
nervous system dopaminergic and other neurochemical sys-
tems [169–171] and enhance autonomic regulation, in part
by modulating activation of the sympathoadrenal system
and HPA axis and by increasing parasympathetic dominance
[165, 172, 173]. In addition, recent controlled trials of ML and
meditation suggest these practices can alter activity, increase
grey matter density and/or volume, and promote functional
connectivity in multiple brain areas involved in the cognitive,
affective, and sensory processing of pain, including the
periaqueductal grey matter, hippocampus, prefrontal cortex,
insula, amygdala, orbitofrontal cortex, thalamus, somatosen-
sory cortex, and anterior cingulate gyrus [157, 158, 163–165,
172, 174–180].
Strengths and Limitations. Strengths of the study include the
community-based approach, rigorous, controlled design, and
the use of multiple well-validated outcomemeasures of direct
relevance to OA, including core outcomes recommended
for knee OA trials of lifestyle/behavioral interventions [134];
treatment expectancies and program adherence were also
measured. The two interventions were matched in terms
of time, setting, and delivery. Both are easy-to-learn prac-
tices that can be performed readily in the home, with
exit questionnaires suggesting high satisfaction with both
programs. Baseline characteristics of the two groups were
similar overall, indicating the randomization was successful
in this study despite the small sample size. Retention and
adherence were excellent and study satisfaction was high in
both groups, further supporting feasibility of both the trial
and the interventions.
This exploratory RCT also has several important limi-
tations. The study did not include a long-term follow-up;
thus, it was not possible to determine if the observed benefits
were sustained over time.The sample size was small, reducing
our ability to detect between-group differences and limiting
generalizability. However, despite the limited power of the
study, the MM group demonstrated both statistically and
clinically significant improvements in all core outcomes and
in four of the five secondary outcomes. Participants assigned
toMMalso demonstrated greater improvements than theML
group in certain domains of knee-related function/QOL, as
well as in mood, sleep, QOL-MH, and fear of movement,
outcomes of clear relevance to OAmanagement. In addition,
observed effect sizes in the MM group were comparable to
or superior to those reported in RCTs of both nonpharmaco-
logic [40, 41, 101–112] and pharmacologic interventions [113–
115].
As this RCT did not include a usual care group, the
relative influence of simple time trends or of the Hawthorne
effect on change in outcomes could not be gauged. Likewise,
due to the lack of an attention control, the influence of
placebo effects cannot be ruled out. However, in this study,
participant treatment expectancies (the primary determinant
of placebo effects) were unrelated or negatively related to
observed improvements; moreover, adjustment for treat-
ment expectations strengthened between group differences in
several measures, but otherwise did not appreciably affect
our findings. Together, these findings suggest that placebo
effects were unlikely to explain the improvements observed
in this study. Although retention was high overall (91%), both
drop-outs were in the MM group, potentially introducing
bias. However, in both cases, withdrawal occurred early
and for reasons unrelated to the intervention, and ITT
analyses yielded results (both the within- and between-
group) similar to those of our primary analyses, suggest-
ing that the influence of differential attrition was likely to
be minimal. Our study was also inadequately powered to
assess the role of potential mediators, limiting conclusions
regarding potential mechanisms. In addition, we did not
include performance-based measures in this exploratory
trial, and our study findings were thus reliant on self-
reported measures of knee pain and function. However,
given that patient perceptions and symptoms are primary
drivers of the healthcare burden and disability associated
with OA [181, 182], our findings are nonetheless clinically
meaningful.The study populationwas predominantly female,
non-Hispanic white, and older, limiting generalizability to
other populations.
5. Conclusions
Findings of this exploratory RCT suggest that a simple MM
and, possibly, ML program may be beneficial for reducing
knee pain and dysfunction, decreasing stress, and improving
mood, sleep, and QOL in older adults with knee OA, with
improvements in knee function, mood, sleep, QOL-MH,
and kinesiophobia that appeared greater in the meditation
group. Improvements in mood, stress, sleep, QOL, and
kinesiophobia were significantly correlated with improve-
ments in several knee pain related outcomes, suggesting a
potential mediating influence of these psychosocial factors.
However, given the small size and exploratory nature of
this RCT, our findings should be interpreted with caution.
Larger controlled trials in multiethnic populations are clearly
needed to confirm and extend these preliminary findings,
to determine the cost-effectiveness of meditation versus
other commonly used treatments for OA, and to investigate
potential underlying mechanisms.
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[3] T. Kendzerska, P. Jüni, L. K. King, R. Croxford, I. Stanaitis,
and G. A. Hawker, “The longitudinal relationship between
hand, hip and knee osteoarthritis and cardiovascular events:
a population-based cohort study,” Osteoarthritis and Cartilage,
vol. 25, no. 11, pp. 1771–1780, 2017.
[4] M. L. Hoops, N. J. Rosenblatt, C. P. Hurt, J. Crenshaw, andM. D.
Grabiner, “Does lower extremity osteoarthritis exacerbate risk
factors for falls in older adults?”Women’s Health Journal, vol. 8,
no. 6, pp. 685–698, 2012.
[5] D. J. Hunter, D. Schofield, and E. Callander, “The individual
and socioeconomic impact of osteoarthritis,” Nature Reviews
Rheumatology, vol. 10, no. 7, pp. 437–441, 2014.
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“Influence of kinesiophobia and catastrophizing on pain and
disability in anterior knee pain patients,” Knee Surgery, Sports
Traumatology, Arthroscopy, vol. 21, no. 7, pp. 1562–1568, 2013.
[134] S. P. Messier, L. F. Callahan, Y. M. Golightly, and F. J. Keefe,
“OARSI clinical trials recommendations: design and conduct
of clinical trials of lifestyle diet and exercise interventions for
osteoarthritis,” Osteoarthritis and Cartilage, vol. 23, no. 5, pp.
787–797, 2015.
[135] S.-S. Kim, W.-K. Min, J.-H. Kim, and B.-H. Lee, “The effects
of VR-based Wii fit yoga on physical function in middle-aged
female LBP patients,” Journal of Physical Therapy Science, vol.
26, no. 4, pp. 549–552, 2014.
[136] K. Jay, M. Brandt, M. D. Jakobsen et al., “Ten weeks of physical-
cognitive-mindfulness training reduces fear-avoidance beliefs
about work-related activity: randomized controlled trial,”
Medicine, vol. 95, no. 34, 2016.
[137] M. C. Davis, A. J. Zautra, L. D. Wolf, H. Tennen, and E. W.
Yeung, “Mindfulness and cognitive-behavioral interventions
for chronic pain: differential effects on daily pain reactivity and
stress reactivity,” Journal of Consulting and Clinical Psychology,
vol. 83, no. 1, pp. 24–35, 2015.
[138] J. A. Turner, M. L. Anderson, B. H. Balderson, A. J. Cook,
K. J. Sherman, and D. C. Cherkin, “Mindfulness-based stress
reduction and cognitive behavioral therapy for chronic low
back pain: Similar effects on mindfulness, catastrophizing, self-
efficacy, and acceptance in a randomized controlled trial,” Pain,
vol. 157, no. 11, pp. 2434–2444, 2016.
[139] E. L. Garland, S. A. Gaylord, O. Palsson, K. Faurot, J. Douglas
Mann, and W. E. Whitehead, “Therapeutic mechanisms of
a mindfulness-based treatment for IBS: effects on visceral
sensitivity, catastrophizing, and affective processing of pain
sensations,” Journal of Behavioral Medicine, vol. 35, no. 6, pp.
591–602, 2012.
[140] J. Molyneux, L. Herrington, and R. Jones, “An investigation into
the effect of a lower limb exercise programme on kinesiophobia
in individuals with knee osteoarthritis,” Osteoarthritis and
Cartilage, vol. 25, p. S407, 2017.
[141] J. Takacs, N. M. Krowchuk, S. J. Garland, M. G. Carpenter,
and M. A. Hunt, “Dynamic balance training improves phys-
ical function in individuals with knee osteoarthritis: a pilot
randomized controlled trial,” Archives of Physical Medicine and
Rehabilitation, vol. 98, no. 8, pp. 1586–1593, 2017.
[142] T. Kahraman, A. T. Ozdogar, P. Yigit et al., “Feasibility of a 6-
month yoga program to improve the physical and psychosocial
status of persons with multiple sclerosis and their family
members,” Explore: The Journal of Science and Healing, vol. 14,
no. 1, pp. 36–43, 2018.
[143] K. A. Williams, J. Petronis, D. Smith et al., “Effect of Iyengar
yoga therapy for chronic low back pain,” Pain, vol. 115, no. 1-2,
pp. 107–117, 2005.
[144] K. J. Sherman, R. D. Wellman, A. J. Cook, D. C. Cherkin, and
R. M. Ceballos, “Mediators of yoga and stretching for chronic
low back pain,” Evidence-Based Complementary and Alternative
Medicine, vol. 2013, Article ID 130818, 11 pages, 2013.
[145] M. Goyal, S. Singh, and E. M. Sibinga, “Meditation programs
for psychological stress and well-being: a systematic review and
meta-analysis,” JAMA Internal Medicine, vol. 174, no. 3, pp. 357–
368, 2014.
[146] W. R. Marchand, “Mindfulness-based stress reduction,
mindfulness-based cognitive therapy, and zen meditation for
depression, anxiety, pain, and psychological distress,” Journal
of Psychiatric Practice, vol. 18, no. 4, pp. 233–252, 2012.
18 Evidence-Based Complementary and Alternative Medicine
[147] K. Innes, T. Selfe, D. Khalsa, and SA. Kandati, “Effects of
meditation vs. music listening on perceived stress, mood, sleep
and quality of life in adults with early memory loss: a pilot
randomized controlled trial,” Journal of Alzheimer’s Disease, vol.
52, no. 4, pp. 1277–1298, 2016.
[148] J-H. Lee, The Effects of Music on Pain: A Review of Systematic
Reviews and Meta-Analysis, Temple University, 2015.
[149] H. Kamioka, K. Tsutani, M. Yamada et al., “Effectiveness of
music therapy: A summary of systematic reviews based on
randomized controlled trials of music interventions,” Patient
Preference and Adherence, vol. 8, pp. 727–754, 2014.
[150] P. Klainin-Yobas, W. N. Oo, P. Y. Suzanne Yew, and Y. Lau,
“Effects of relaxation interventions on depression and anxiety
among older adults: a systematic review,” Aging & Mental
Health, vol. 19, no. 12, pp. 1043–1055, 2015.
[151] W.-L. Lee, H.-C. Sung, S.-H. Liu, and S.-M. Chang, “Meditative
music listening to reduce state anxiety in patients during
the uptake phase before positron emission tomography (PET)
scans,” British Journal of Radiology, vol. 90, no. 1070, 2017.
[152] A.-P. Trouvin and S. Perrot, “Pain in osteoarthritis. Implications
for optimal management,” Joint Bone Spine, 2017.
[153] M. de Rooij, M. van der Leeden, M. W. Heymans et al.,
“Prognosis of pain and physical functioning in patients with
knee osteoarthritis: a systematic review and meta-analysis,”
Arthritis Care & Research, vol. 68, no. 4, pp. 481–492, 2016.
[154] A. M. Rathbun, E. A. Stuart, M. Shardell, M. S. Yau, M.
Baumgarten, and M. C. Hochberg, “Dynamic effects of depres-
sive symptoms on osteoarthritis knee pain,” Arthritis Care &
Research, 2017.
[155] K. Kroenke, J. Wu, M. J. Bair, E. E. Krebs, T. M. Damush, and
W. Tu, “Reciprocal relationship between pain and depression: a
12-month longitudinal analysis in primary care,”The Journal of
Pain, vol. 12, no. 9, pp. 964–973, 2011.
[156] M. A. Combs and B. E. Thorn, “Yoga attitudes in chronic low
back pain: Roles of catastrophizing and fear of movement,”
Complementary Therapies in Clinical Practice, vol. 21, no. 3, pp.
160–165, 2015.
[157] C. E. Dobek, M. E. Beynon, R. L. Bosma, and P. W. Stroman,
“Music modulation of pain perception and pain-related activity
in the brain, brain stem, and spinal cord: a functional magnetic
resonance imaging study,”The Journal of Pain, vol. 15, no. 10, pp.
1057–1068, 2014.
[158] F. Zeidan and D. R. Vago, “Mindfulness meditation–based pain
relief: a mechanistic account,” Annals of the New York Academy
of Sciences, vol. 1373, no. 1, pp. 114–127, 2016.
[159] J. A. Grant, “Meditative analgesia: the current state of the field,”
Annals of the New York Academy of Sciences, vol. 1307, no. 1, pp.
55–63, 2014.
[160] D. J. J. Wang, H. Rao, M. Korczykowski et al., “Cerebral blood
flow changes associated with different meditation practices
and perceived depth of meditation,” Psychiatry Research: Neu-
roimaging, vol. 191, no. 1, pp. 60–67, 2011.
[161] A. B. Newberg, N. Wintering, M. R. Waldman, D. Amen, D. S.
Khalsa, and A. Alavi, “Cerebral blood flow differences between
long-term meditators and non-meditators,” Consciousness and
Cognition, vol. 19, no. 4, pp. 899–905, 2010.
[162] K. Rubia, “The neurobiology of meditation and its clinical
effectiveness in psychiatric disorders,”Biological Psychology, vol.
82, no. 1, pp. 1–11, 2009.
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